Aetiology and natural history of Parkinson's disease.
暂无分享,去创建一个
[1] T. Chase,et al. Fenfluramine hydrochloride treatment of parkinsonism. , 1977, Archives of neurology.
[2] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[3] Glutamic-acid decarboxylase and choline acetylase in Huntington's chorea and Parkinson's disease. , 1973, Lancet.
[4] A. Hakim,et al. BASIS OF DEMENTIA IN PARKINSON'S DISEASE , 1978, The Lancet.
[5] R. Spehlmann,et al. DOPAMINE ACETYLCHOLINE IMBALANCE IN PARKINSON'S DISEASE Possible Regenerative Overgrowth of Cholinergic Axon Terminals , 1976, The Lancet.
[6] J. Siegfried,et al. Mortality among Parkinson patients treated with L-dopa combined with a decarboxylase inhibitor. , 1976, European neurology.
[7] C. Marsden,et al. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. , 1978, British medical journal.
[8] A. Lees,et al. Baclofen in Parkinson's disease. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[9] U. Rinne. Recent advances in research on Parkinsonism. , 1978, Acta neurologica Scandinavica. Supplementum.
[10] F. Mcdowell,et al. Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients. , 1975, Annals of internal medicine.
[11] M. Pollock,et al. The prevalence, natural history and dementia of Parkinson's disease. , 1966, Brain : a journal of neurology.
[12] C. Marsden,et al. Sodium valproate in the treatment of levodopa-induced dyskinesia. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[13] J. Pearce. The extrapyramidal disorder of Alzheimer's disease. , 1974, European neurology.
[14] A. Barbeau. Six years of high-level levodopa therapy in severely akinetic parkinsonian patients. , 1976, Archives of neurology.